India’s parliamentary panel has recommended decentralising medical device approvals to State Licensing Authorities. The aim is to reduce delays, improve efficiency, and strengthen competitiveness. The reforms target bottlenecks in CDSCO processes, especially for...
SUGAM is the official CDSCO license application portal. It is a single-window online system for regulatory submissions. It ensures faster approvals and clear digital tracking of submissions. Central Drugs Standard Control Organization (CDSCO) has announced a new SUGAM...
FDA has three types of regulatory pathways, namely 510(k), De Novo, PMA, for medical device approval. US FDA premarket approval (PMA) is the most rigorous and stringent regulatory pathway. High-risk devices (Class III devices that sustain life or pose significant...
Mid-project design changes can significantly delay or derail regulatory approvals. This is because they alter the validated product definition, thereby requiring new risk assessments, verification/validation, and updates to technical documentation. Hence, they often...
A pacemaker is a small, implanted device used to treat heart rhythm disorders (arrhythmias). Thus, a pacemaker has a considerable impact in the cardiovascular field of medicine. Starting a pacemaker manufacturing business in India is a highly lucrative opportunity. It...
India’s catheter manufacturing business market shows strong potential. It is driven by rising demand for vascular access and urinary catheters and government incentives for medical devices. India currently imports a significant share of catheters. Hence, local...